Bifeprunox versus placebo for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bifeprunox Versus Placebo for Schizophrenia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434689/all/Ginkgo_biloba_for_cognitive_impairment_and_dementia_Edited__no_change_to_conclusions_. Accessed 18 April 2024.
Bifeprunox versus placebo for schizophrenia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434689/all/Ginkgo_biloba_for_cognitive_impairment_and_dementia_Edited__no_change_to_conclusions_. Accessed April 18, 2024.
Bifeprunox versus placebo for schizophrenia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434689/all/Ginkgo_biloba_for_cognitive_impairment_and_dementia_Edited__no_change_to_conclusions_
Bifeprunox Versus Placebo for Schizophrenia [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434689/all/Ginkgo_biloba_for_cognitive_impairment_and_dementia_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bifeprunox versus placebo for schizophrenia
ID - 434689
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434689/all/Ginkgo_biloba_for_cognitive_impairment_and_dementia_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -